Biodel AG’s Microscopic Solution Could Solve Huge Problems - KingsCrowd

Analyst Report: Upgrade for access Biodel AG’s Microscopic Solution Could Solve Huge Problems

Biodel AG’s microbial method for reviving soil is extremely promising, making this moonshot startup an intriguing investment opportunity.

 
Details
Company: Biodel AG on Wefunder 2022
Security Type: Convertible Note
Valuation: $25,000,000
Min Investment: $250
Platform: Wefunder
Deadline: Jan 20, 2023
$1,500,000
Vin Narayanan - December 2nd

Houston, We Have Company

Note: This recommendation was co-authored by KingsCrowd Senior Investment Research Analyst Léa Bouhelier-Gautreau.


Moonshot companies are tricky to evaluate. By definition, moonshots are bold, audacious, innovative attempts to solve massive problems. And if the solution is successful, it can be immensely profitable for investors and beneficial for society.

Moonshots are also incredibly risky. Such innovative solutions are difficult to build. And often, it takes a long time before society adopts a moonshot solution. It’s hard to overcome decades of doing something the same way.

That’s why timing is incredibly important when investing in moonshots. We know that many early stage moonshot companies are at least a decade away from succeeding. Investing in them often means waiting a long time before seeing any returns.

But every now and then, a moonshot company arrives on the scene at precisely the right moment — when a problem is so big and pressing that the world needs to adopt a working solution right away. And if a moonshot company has a working solution — and clear pathway to growth and monetization — that dramatically reduces the company’s risk profile and makes it extremely attractive to startup investors. 

We believe Biodel AG is one of these special moonshot companies. 

Pay Annually
and save 17%

This article requires: Edge Pro

Full site access including KingsCrowd's qualitative analyst reports.

$
49.95 /month
41.58 /annually
 

What's included

  • Everything in Edge, plus
  • Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
  • Search and filter based on Analyst Reports
  • In-depth risk ratings for every raise

Get access to the first and only premium analytics and rating platform that enables informed startup investments.

Join the KingsCrowd insiders!

Sign up for our 3 minute newsletter with fresh takes on the investments you should know.

We care about the protection of your data. Read our Privacy Policy.